Suping Li

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Topics

Radiofrequency Ablation

Reactive Oxygen Species

Top Venues

Nature communications

Bioconjugate chemistry

Accounts of chemical research

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan Liang, Yunkai Qie, Jing Yang, Ranfeng Wu, Shuang Cui, Yu-Liang Zhao, Greg J Anderson, Guangjun Nie, Suping Li, Cheng Zhang
Programming conformational cooperativity to regulate allosteric protein-oligonucleotide signal transduction. Nature communications 14 (1) (2023)
Suping Li, Zefang Lu, Suying Wu, Tianjiao Chu, Bozhao Li, Feilong Qi, Yuliang Zhao, Guangjun Nie
The dynamic role of platelets in cancer progression and their therapeutic implications. Nature reviews. Cancer (2023)
Tianjiao Chu, Bowei Cao, Peina Wang, Bozhao Li, Jinna Ren, Guangjun Nie, Jingyan Wei, Suping Li
Tumor-Targeted Delivery of IL-2 by Fusing with a pH Low Insertion Peptide for Antitumor Immunotherapy. Bioconjugate chemistry (2023)
Bozhao Li, Feilong Qi, Fei Zhu, Zefang Lu, Meiqi Wang, Tianjiao Chu, Suying Wu, Jingyan Wei, Zhenchuan Song, Saraswati Sukumar, Cheng Zhang, Jiang-Fei Xu, Suping Li, Guangjun Nie
Nanoparticle-based combination therapy enhances fulvestrant efficacy and overcomes tumor resistance in ER-positive breast cancer. Cancer research (2023)
Bozhao Li, Xiuping Zhang, Zhouliang Wu, Tianjiao Chu, Zhenlin Yang, Shuai Xu, Suying Wu, Yunkai Qie, Zefang Lu, Feilong Qi, Minggen Hu, Guodong Zhao, Jingyan Wei, Yuliang Zhao, Guangjun Nie, Huan Meng, Rong Liu, Suping Li
Reducing Postoperative Recurrence of Early-Stage Hepatocellular Carcinoma by a Wound-Targeted Nanodrug. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (20) (2022)
Bozhao Li, Tianjiao Chu, Jingyan Wei, Yinlong Zhang, Feilong Qi, Zefang Lu, Chao Gao, Tianjiao Zhang, Ershuai Jiang, Junchao Xu, Jiaqi Xu, Suping Li, Guangjun Nie
Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment. Nano letters 21 (6) (2021)
Suping Li, Yinlong Zhang, Shih-Hsin Ho, Bozhao Li, Meifang Wang, Xiongwei Deng, Na Yang, Guangna Liu, Zefang Lu, Junchao Xu, Quanwei Shi, Jing-Yan Han, Lirong Zhang, Yan Wu, Yu-Liang Zhao, Guangjun Nie
Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles. Nature biomedical engineering 4 (7) (2020)
Xin Zeng, Jie Sun, Suping Li, Jiyun Shi, Han Gao, Wei Sun Leong, Yiqi Wu, Minghui Li, Chengxin Liu, Ping Li, Jing Kong, Yi-Zhou Wu, Guangjun Nie, Yuming Fu, Gen Zhang
Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agent. Nature communications 11 (1) (2020)
Laifeng Ding, Congcong Zhang, Zhigang Liu, Qingxia Huang, Yinlong Zhang, Suping Li, Guangjun Nie, Huiru Tang, Yulan Wang
Metabonomic Investigation of Biological Effects of a New Vessel Target Protein tTF-pHLIP in a Mouse Model. Journal of proteome research 19 (1) (2019)
Marzieh Geranpayehvaghei, Quanwei Shi, Baochang Zhao, Suping Li, Junchao Xu, Mohammad Taleb, Hao Qin, Yinlong Zhang, Khosro Khajeh, Guangjun Nie
Targeting Delivery of Platelets Inhibitor to Prevent Tumor Metastasis. Bioconjugate chemistry 30 (9) (2019)
Zifu Li, Chunzhi Di, Suping Li, Xiangliang Yang, Guangjun Nie
Smart Nanotherapeutic Targeting of Tumor Vasculature. Accounts of chemical research 52 (9) (2019)
Shaoli Liu, Yinlong Zhang, Xiao Zhao, Jing Wang, Chunzhi Di, Ying Zhao, Tianjiao Ji, Keman Cheng, Yongwei Wang, Long Chen, Yingqiu Qi, Suping Li, Guangjun Nie
Tumor-Specific Silencing of Tissue Factor Suppresses Metastasis and Prevents Cancer-Associated Hypercoagulability. Nano letters 19 (7) (2019)
Rui Bao, Yanpu Wang, Jianhao Lai, Hua Zhu, Yang Zhao, Suping Li, Nan Li, Jing Huang, Zhi Yang, Fan Wang, Zhaofei Liu
Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature. Molecular pharmaceutics 16 (1) (2018)